Probiotic Lactobacillus Acidophilus and L. Casei Mix Sensitize Colorectal Tumoral Cells to 5-Fluorouracil-Induced Apoptosis
The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
To assess the potential of Lactobacillus acidophilus and Lactobacillus casei strains to increase the apoptosis of a colorectal cancer cell line in the presence of 5-fluorouracil (5-FU), LS513 colorectal cancer cells were treated for 48 h with increasing concentrations of these lactic acid bacteria (LAB) in the presence of 100 mu g/ml of 5-FU. In the presence of 10(8) CFU/ml of live LAB, the apoptotic efficacy of the 5-FU increased by 40%, and the phenomenon was dose dependent. Moreover, irradiation-inactivated LAB caused the same level of induction, whereas microwave-inactivated LAB reduced the apoptotic capacity of the 5-FU. When cells were treated with a combination of live LAB and 5-FU, a faster activation of caspase-3 protein was observed, and the p21 protein seems to be downregulated. These results suggest that live L. acidophilus and L. casei are able to increase the apoptosis-induction capacity of 5-FU. The mechanisms of action are still not elucidated, and more research is needed to understand them. This is the first set of experiments demonstrating that some strains of LAB can enhance the apoptosis-induction capacity of the 5-FU. Based on these results, it is possible to speculate that LAB or probiotics could be used as an adjuvant treatment during anticancer chemotherapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It has been also reported in several studies that Lactobacilli may stimulate host’s immune cells such as NK cells or dendritic cells (DC) or TH1 response, which, in turn, leads to the elimination of cancerous or precancerous cells, although the exact bacterial bioproduct mediating such stimulatory effect still needs to be identified [45,46,47,48].”
From Gut Microbiota and Cancer: From Pathogenesis to Therapy (2019) · cites this paper as [47]
Citations
Cites
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T., & Thun, M. J. (2008) · CA: A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0010 · Cited by 10,188
Analysis of apoptosis by propidium iodide staining and flow cytometry
Riccardi, C., & Nicoletti, I. (2006) · Nature Protocols · doi:10.1038/nprot.2006.238 · Cited by 1,685 · cited 1×
“The apoptosis evaluation was done by flow cytometry in presence of propidium iodide (according to (18)).”
MethodHaupt, S., Berger, M., Goldberg, Z., & Haupt, Y. (2003) · Journal of Cell Science · doi:10.1242/jcs.00739 · Cited by 1,136 · cited 2×
“Moreover, Borralho et al. (33) demonstrated that 5-FU exerts its cytotoxic effects, in part, through a p53/Fas-dependent apoptotic pathway that involves Bax translocation and mitochondrial permeabilization.”
BackgroundGaldeano, C. M., & Perdigón, G. (2006) · Clinical and Vaccine Immunology · doi:10.1128/cvi.13.2.219-226.2006 · Cited by 535 · cited 1×
“First, in this type of experiment, it was not possible to verify if immune system modulation could interfere in this proapoptotic effect, although it is known that the modulation of the immune system is a strain-specific property that is widely recognized for many probiotic LAB (22,23).”
BackgroundAdolfsson, O., Meydani, S. N., & Russell, R. M. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.2.245 · Cited by 531 · cited 1×
“The preservative role and health benefits of fermented milk (7), kefir (8), and yogurt (9) are now recognized.”
BackgroundSystemic Treatment of Colorectal Cancer
Wolpin, B. M., & Mayer, R. J. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.098 · Cited by 504 · cited 13×
“Food and Drug Administration (FDA) for the treatment of CRC (5).”
BackgroundInfluentialCancer burden in the aged: An epidemiologic and demographic overview
Yancik, R. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19971001)80:7<1273::aid-cncr13>3.0.co;2-4 · Cited by 473
Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria
Foligne, B. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i2.236 · Cited by 432 · cited 1×
“First, in this type of experiment, it was not possible to verify if immune system modulation could interfere in this proapoptotic effect, although it is known that the modulation of the immune system is a strain-specific property that is widely recognized for many probiotic LAB (22,23).”
BackgroundÖsterlund, P., Ruotsalainen, T., Korpela, R., Saxelin, M., Ollus, A., Valta, P., Kouri, M., Elomaa, I., & Joensuu, H. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603990 · Cited by 405 · cited 1×
“(40) demonstrated that the consumption of gelatine capsules twice daily, containing about 1 to 2 × 1010 of L.”
BackgroundSensitization of Cancer Cells Treated With Cytotoxic Drugs to Fas-Mediated Cytotoxicity
Micheau, O., Solary, E., Hammann, A., Martin, F., & Dimanche-Boitrel, M.-T. (1997) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/89.11.783 · Cited by 281 · cited 8×
“The treatment of LS513 cells with 5-FU increased the expression of p21; but unlike what was observed with p53 and Fas, the combination of 5-FU and live or microwave-inactivated LAB resulted in changes of p21 protein expression.”
BackgroundInfluentialThe role of probiotic bacteria in cancer prevention
Hirayama, K., & Rafter, J. (2000) · Microbes and Infection · doi:10.1016/s1286-4579(00)00357-9 · Cited by 267 · cited 1×
“The consumption of probiotics can result in a theoretical prevention of CRC by stimulating the immune system (11); reducing the incidence of microbial infection (reviewed in (12)); binding toxic compounds (13); reducing the activity of carcinogenic fecal enzymes such as azoreductase, β-glucuronidase, and nitroreductas…”
BackgroundLactobacillus‐ and bifidobacterium‐mediated antigenotoxicity in the colon of rats
Pool‐Zobel, B. L., Neudecker, C., Domizlaff, I., Ji, S., Schillinger, U., Rumney, C., Moretti, M., Vilarini, I., Scassellati‐Sforzolini, R., & Rowland, I. (1996) · Nutrition and Cancer · doi:10.1080/01635589609514492 · Cited by 256
Clinical Indications for Probiotics: An Overview
Goldin, B. R., & Gorbach, S. L. (2008) · Clinical Infectious Diseases · doi:10.1086/523333 · Cited by 230 · cited 1×
“The consumption of probiotics can result in a theoretical prevention of CRC by stimulating the immune system (11); reducing the incidence of microbial infection (reviewed in (12)); binding toxic compounds (13); reducing the activity of carcinogenic fecal enzymes such as azoreductase, β-glucuronidase, and nitroreductas…”
BackgroundNita, M., Nagawa, H., Tominaga, O., Tsuno, N., Fujii, S., Sasaki, S., Fu, C.-G., Takenoue, T., Tsuruo, T., & Muto, T. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.617 · Cited by 182 · cited 1×
“Many studies have demonstrated the proapoptotic effect of the 5-FU in human cell lines (24,25).”
BackgroundBeausoleil, M., Fortier, N., Guénette, S., L’Ecuyer, A., Savoie, M., Franco, M., Lachaîne, J., & Weiss, K. (2007) · Canadian Journal of Gastroenterology · doi:10.1155/2007/720205 · Cited by 162 · cited 1×
“casei) probiotic fermented milk was safe and effective in the prevention of antibiotic-associated diarrhea in hospitalized patients (15).”
BackgroundLactic acid bacteria and cancer: mechanistic perspective
Rafter, J. (2002) · British Journal of Nutrition · doi:10.1079/bjn2002633 · Cited by 162
Mahyar-Roemer, M., & Roemer, K. (2001) · Oncogene · doi:10.1038/sj.onc.1204440 · Cited by 162
The potential of TRAIL for cancer chemotherapy
Nagane, M., Huang, H.-J. S., & Cavenee, W. K. (2001) · APOPTOSIS · doi:10.1023/a:1011336726649 · Cited by 161 · cited 1×
“Other systems could induce cell apoptosis through, by example, activation of the tumor necrosis factor-related apoptosis inducing ligand (TRAIL) system including its death receptors, DR4 and DR5, as well as its decoy receptors DcR1 and DcR2 (34).”
BackgroundKim, Y., Lee, D. K., Kim, D., Cho, J., Yang, J. W., Chung, M.-J., Kim, K., & Ha, N. (2008) · Archives of Pharmacal Research · doi:10.1007/s12272-001-1180-y · Cited by 153 · cited 1×
“Some studies conducted on animal models have suggested that the reduction of the activity of potentially carcinogenic fecal enzymes (β-glucuronidase, azoreductase, nitroreductase) could result in a reduced incidence of cancer (41).”
BackgroundMachover, D. (1997) · Cancer · Cited by 135
Signaling pathways and effector mechanisms pre-programmed cell death
Blatt, N. B., & Glick, G. D. (2001) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(01)00041-4 · Cited by 133 · cited 1×
“This latter enzyme is cleaved, by active caspase 8 or 9, into a large and one small subunits, which then dimerize; two large and two small subunits are required for full enzymatic activity (30).”
BackgroundRoller, M., Femia, A. P., Caderni, G., Rechkemmer, G., & Watzl, B. (2004) · British Journal of Nutrition · doi:10.1079/bjn20041289 · Cited by 133 · cited 2×
“The consumption of probiotics can result in a theoretical prevention of CRC by stimulating the immune system (11); reducing the incidence of microbial infection (reviewed in (12)); binding toxic compounds (13); reducing the activity of carcinogenic fecal enzymes such as azoreductase, β-glucuronidase, and nitroreductas…”
BackgroundMillette, M., Luquet, F. M., & Lacroix, M. (2006) · Letters in Applied Microbiology · doi:10.1111/j.1472-765x.2006.02060.x · Cited by 128 · cited 1×
“(16) established the antimicrobial capacity of this fermented milk against various bacterial pathogens and suggested that the production of organic acids and bacteriocin-like inhibitory substances was involved in the inhibitory activity.”
BackgroundSelf-citationProbiotics: Functionality and commercial status
Scheinbach, S. (1998) · Biotechnology Advances · doi:10.1016/s0734-9750(98)00002-0 · Cited by 126 · cited 1×
“The preservative role and health benefits of fermented milk (7), kefir (8), and yogurt (9) are now recognized.”
BackgroundAntiproliferative effect of fermented milk on the growth of a human breast cancer cell line
Biffi, A., Coradini, D., Larsen, R., Riva, L., & Di Fronzo, G. (1997) · Nutrition and Cancer · doi:10.1080/01635589709514558 · Cited by 125 · cited 1×
“Moreover, some components of LAB or metabolites produced during milk fermentation by LAB are known to exert antiproliferative effects on cancer cells of various types in vitro ( 26 , 27 , 28 ).”
BackgroundPrevention of Colorectal Cancer: Diet, Chemoprevention, and Lifestyle
Marshall, J. R. (2008) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2007.12.008 · Cited by 108
p21WAF1/CIP1 Inhibits Initiator Caspase Cleavage by TRAIL Death Receptor DR4
Xu, S., & El‐Deiry, W. S. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2247 · Cited by 97 · cited 1×
“This role for p21 has been previously described ( 36 , 37 , 38 ).”
Baricault, L., Denariaz, G., Houri, J.-J., Bouley, C., Sapin, C., & Trugnan, G. (1995) · Carcinogenesis · doi:10.1093/carcin/16.2.245 · Cited by 96 · cited 1×
“Moreover, some components of LAB or metabolites produced during milk fermentation by LAB are known to exert antiproliferative effects on cancer cells of various types in vitro ( 26 , 27 , 28 ).”
BackgroundBcl-2/Bax protein ratio predicts 5-fluorouracil sensitivity independently of p53 status
Mirjolet, J.-F., Barberi‐Heyob, M., Mirjolet, C., Peyrat, J.-P., Abecassis, J., Millon, R., & Merlin, J. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1455 · Cited by 95 · cited 1×
“Many studies have demonstrated the proapoptotic effect of the 5-FU in human cell lines ( 24 , 25 ).”
BackgroundGanjam, L. S., Thornton, W. H., Marshall, R. T., & MacDonald, R. S. (1997) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(97)76183-6 · Cited by 74 · cited 1×
“Moreover, some components of LAB or metabolites produced during milk fermentation by LAB are known to exert antiproliferative effects on cancer cells of various types in vitro ( 26 , 27 , 28 ).”
BackgroundPark, E., Jeon, G.-I., Park, J.-S., & Paik, H.-D. (2007) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.30.569 · Cited by 66 · cited 1×
“Consumption of probiotics as a dietary supplement has been reported to show some anticancer capacity (11,39).”
BackgroundProbiotics and the incidence of colorectal cancer: when evidence is not evident
Capurso, G., Marignani, M., & Fave, G. D. (2006) · Digestive and Liver Disease · doi:10.1016/s1590-8658(07)60010-3 · Cited by 59 · cited 1×
“The consumption of probiotics can result in a theoretical prevention of CRC by stimulating the immune system (11); reducing the incidence of microbial infection (reviewed in (12)); binding toxic compounds (13); reducing the activity of carcinogenic fecal enzymes such as azoreductase, β-glucuronidase, and nitroreductas…”
BackgroundInteraction of bifidobacteria with the gut and their influence in the immune function
Perdig髇, G., Locascio, M., Medici, M., Pesce de Ruiz Holagado, A., & Oliver, G. (2003) · BIOCELL · doi:10.32604/biocell.2003.27.001 · Cited by 54 · cited 1×
“The preservative role and health benefits of fermented milk (7), kefir (8), and yogurt (9) are now recognized.”
BackgroundBorralho, P. M., da Silva, I. M., Aranha, M. M., Albuquerque, C. M., Leitão, C. N., Steer, C. J., & Rodrigues, C. M. P. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.09.005 · Cited by 52 · cited 1×
“( 33 ) demonstrated that 5-FU exerts its cytotoxic effects, in part, through a p53/Fas-dependent apoptotic pathway that involves Bax translocation and mitochondrial permeabilization.”
BackgroundClinical overview: adjuvant therapy of gastrointestinal cancer
Macdonald, J. S. (2004) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-004-0880-4 · Cited by 50 · cited 3×
“Furthermore, a tumoral cell line presenting a wild-type p53, a gene that is altered in a majority of human CRC cells (21), was used in this study.”
BackgroundMethodCharacterization of probiotic properties ofLactobacillusstrains
Millette, M., Luquet, F. M., Ruiz, M. T., & Lacroix, M. (2008) · Dairy Science and Technology · doi:10.1051/dst:2008018 · Cited by 49 · cited 1×
“( 17 ) demonstrated that these lactobacilli were acid and bile resistant.”
BackgroundSelf-citationCiccolini, J., Peillard, L., Evrard, A., Cuq, P., Aubert, C., Pèlegrin, A., Formento, P., Milano, G. A., & Catalin, J. (2000) · PubMed · Cited by 46
Takahashi, H., Yoneda, K., Tomimoto, A., Endo, H., Fujisawa, T., Iida, H., Mawatari, H., Nozaki, Y., Ikeda, T., Akiyama, T., et al. (2007) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fm0070022 · Cited by 21 · cited 1×
“Many epidemiological and clinical studies have demonstrated that lifestyle, including the frequency of physical activity and especially the diet, can reduce the incidence of CRC ( 19 , 20 ).”
BackgroundThe handling of metastatic colorectal cancer
Fornarini, G., Guglielmi, A., & Sobrero, A. F. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi710 · Cited by 5 · cited 1×
“Today, combination of 5-FU with novel molecules have improved the RR in the first-line treatment of advanced CRC to 40–50%, the PFS is approximately 8 mo, and the median survival time is 15 to 20 mo (3,4).”
Backgroundp21( WAF1/CIP1) : un inhibiteur de l'apoptose.
Javelaud, D., & Besançon, F. (2000) · médecine/sciences · doi:10.4267/10608/1633 · Cited by 1
Research works printed but not linked: 6
- Canadian Cancer Statistics, 2008
- 10.1002/(SICI)1097-0142(19971001)80:7<1179::AID-CNCR1>3.0.CO;2-G · doi:10.1002/(sici)1097-0142(19971001)80:7<1179::aid-cncr1>3.0.co;2-g
- 2006, Probiotics in food health and nutritional properties and guidelines for evaluation
- Macdonald J S, 2004, Cancer Chemother Pharmacol, 54, S4
- Ciccolini J, 2000, Clin Cancer Res, 6, 1529
- Javelaud J, 2000, Med Sci, 16, 265
Cited by
Gut Microbiota and Cancer: From Pathogenesis to Therapy
Vivarelli, S., Salemi, R., Candido, S., Falzone, L., Santagati, M., Stefani, S., Torino, F., Banna, G. L., Tonini, G., & Libra, M. (2019) · Cancers · doi:10.3390/cancers11010038 · Cited by 586
Anticancer effects of the microbiome and its products
Zitvogel, L., Daillère, R., Roberti, M. P., Routy, B., & Kroemer, G. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.44 · Cited by 538
Tiptiri-Kourpeti, A., Spyridopoulou, K., Santarmaki, V., Aindelis, G., Tompoulidou, E., Lamprianidou, E. E., Saxami, G., Ypsilantis, P., Lampri, E. S., Simopoulos, C., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0147960 · Cited by 319
“Moreover, some strains of LAB can enhance apoptosis-inducing capacity of chemotherapeutic agents [59].”
BackgroundThe Role of Probiotics in Cancer Prevention
Śliżewska, K., Markowiak-Kopeć, P., & Śliżewska, W. (2020) · Cancers · doi:10.3390/cancers13010020 · Cited by 282
“Lactobacillus casei against LS513 gastric cell lines through cellular apoptosis [17].”
Mechanisms and therapeutic effectiveness of lactobacilli
Di Cerbo, A., Palmieri, B., Aponte, M., Morales-Medina, J. C., & Iannitti, T. (2016) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2015-202976 · Cited by 266
“74 75 – 77 These activities have been ascribed to the alteration of gut microbiota and, subsequently, to the inhibition or the induction of colonic enzymes controlling the growth of harmful bacteria, improving immune function and stimulating the production of metabolites possessing antitumour…”
Background
Metadata
- Authors
- Baldwin∗, C., Millette∗, M., Oth †, D., Ruiz, M. T., Luquet, F.-M., & Lacroix, M.
- Affiliations
- Bio-K+ International (Canada) (CA)
- Institut National de la Recherche Scientifique (CA)
- ORCID
- Lacroix, Monique
- Venue
- Nutrition and Cancer
- Publisher
- Informa UK Limited
- Published
- 2010-04-05
- Volume
- 62
- Issue
- 3
- Pages
- 371-378
- ISSN
- 0163-5581 (ISSN-L)
- 1532-7914
- OpenAlex
- W2057808496
- Cited by
- 170
- References
- 39
- Citations by year
- 2026: 9 · 2025: 9 · 2024: 16 · 2023: 14 · 2022: 22 · 2021: 20 · 2020: 25 · 2019: 8 · 2018: 6 · 2017: 8 · 2016: 6 · 2015: 11 · 2014: 5 · 2013: 6 · 2012: 3
- FWCI
- 5.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nutrition and Cancer (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- EspaceINRS (National Institute for Scientific Research (Canada)) (submittedVersion)
- Funders
- U.S. Food and Drug Administration
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
- Keywords
- Lactobacillus acidophilus, Lactobacillus casei, probiotics, lactic acid bacteria, 5-fluorouracil, apoptosis, colorectal cancer, caspase-3, p21, adjuvant chemotherapy, radiation inactivation
- MeSH terms
- Antimetabolites, Antineoplastic, Fluorouracil, Humans, Lactobacillus acidophilus, Lacticaseibacillus casei, Colorectal Neoplasms, Apoptosis, Probiotics, Cell Line, Tumor, Cyclin-Dependent Kinase Inhibitor p21, Caspase 3
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.